23.21
price down icon0.17%   -0.04
after-market Dopo l'orario di chiusura: 23.21
loading
Precedente Chiudi:
$23.25
Aprire:
$23.25
Volume 24 ore:
584.35K
Relative Volume:
0.69
Capitalizzazione di mercato:
$1.13B
Reddito:
$681.75M
Utile/perdita netta:
$70.47M
Rapporto P/E:
16.01
EPS:
1.45
Flusso di cassa netto:
$173.19M
1 W Prestazione:
-2.93%
1M Prestazione:
-11.55%
6M Prestazione:
+26.62%
1 anno Prestazione:
+2.07%
Intervallo 1D:
Value
$22.82
$23.55
Intervallo di 1 settimana:
Value
$22.82
$24.36
Portata 52W:
Value
$11.16
$27.98

Pacira Biosciences Inc Stock (PCRX) Company Profile

Name
Nome
Pacira Biosciences Inc
Name
Telefono
650-242-8052
Name
Indirizzo
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Name
Dipendente
790
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
PCRX's Discussions on Twitter

Confronta PCRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
PCRX
Pacira Biosciences Inc
23.21 1.13B 681.75M 70.47M 173.19M 1.45
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
10.36 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.08 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.26 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.42 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.05 20.17B 16.54B -1.64B 749.00M -1.45

Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-30 Aggiornamento Truist Sell → Hold
2024-08-13 Downgrade Truist Buy → Sell
2024-08-12 Downgrade JP Morgan Overweight → Underweight
2024-08-12 Downgrade Piper Sandler Overweight → Neutral
2024-08-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-08-12 Downgrade Raymond James Outperform → Mkt Perform
2024-07-03 Downgrade Barclays Overweight → Equal Weight
2024-03-07 Ripresa JP Morgan Overweight
2023-12-20 Iniziato Raymond James Outperform
2023-08-03 Aggiornamento TD Cowen Market Perform → Outperform
2023-01-31 Ripresa Wedbush Outperform
2022-10-21 Ripresa Jefferies Buy
2022-01-03 Ripresa JP Morgan Overweight
2021-07-26 Aggiornamento JP Morgan Neutral → Overweight
2021-04-21 Ripresa JP Morgan Neutral
2021-04-09 Iniziato Berenberg Buy
2021-04-07 Ripresa RBC Capital Mkts Outperform
2021-02-11 Downgrade Northland Capital Outperform → Market Perform
2021-01-21 Downgrade SVB Leerink Outperform → Mkt Perform
2020-09-21 Aggiornamento Northland Capital Market Perform → Outperform
2020-07-06 Reiterato Needham Buy
2020-05-27 Iniziato Guggenheim Neutral
2020-04-07 Iniziato Northland Capital Outperform
2020-03-20 Aggiornamento SVB Leerink Mkt Perform → Outperform
2020-02-24 Reiterato H.C. Wainwright Buy
2020-01-24 Iniziato SunTrust Buy
2020-01-23 Iniziato SunTrust Buy
2019-11-06 Iniziato BTIG Research Buy
2019-06-11 Iniziato Barclays Overweight
2019-05-06 Aggiornamento Mizuho Underperform → Neutral
2019-05-02 Aggiornamento Stifel Sell → Hold
2019-02-01 Downgrade Mizuho Neutral → Underperform
2018-08-06 Downgrade BofA/Merrill Buy → Neutral
2018-04-09 Reiterato H.C. Wainwright Buy
2018-03-21 Reiterato Mizuho Neutral
2018-02-16 Downgrade Needham Buy → Hold
2018-01-19 Iniziato Seaport Global Securities Buy
2018-01-04 Reiterato Canaccord Genuity Buy
2018-01-03 Iniziato Leerink Partners Mkt Perform
Mostra tutto

Pacira Biosciences Inc Borsa (PCRX) Ultime notizie

pulisher
Jun 18, 2025

Is the Options Market Predicting a Spike in Pacira BioSciences Stock? - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

Investors in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) Should Contact the Shareholders Foundation in Connection with Lawsuit - Newswire :) Press Release Distribution

Jun 18, 2025
pulisher
Jun 18, 2025

Pacira BioSciences Debuts Inspiring New Film Highlighting - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025 - GlobeNewswire Inc.

Jun 18, 2025
pulisher
Jun 18, 2025

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Business Upturn

Jun 17, 2025
pulisher
Jun 17, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 17, 2025
pulisher
Jun 16, 2025

When the Price of (PCRX) Talks, People Listen - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 15, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 15, 2025
pulisher
Jun 15, 2025

Rhumbline Advisers Sells 9,754 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

GAMMA Investing LLC Grows Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Pacira Pharmaceuticals Stockholders Approve Amended Incentive Plan - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

Have Pacira BioSciences Insiders Been Selling Stock? - simplywall.st

Jun 12, 2025
pulisher
Jun 11, 2025

Pacira (PCRX) Shares Promising Long-Term Data for Osteoarthritis Gene Therapy | PCRX Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences Unveils Three-Year Clinical Data - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences (NASDAQ:PCRX) Seems To Use Debt Quite Sensibly - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 08, 2025

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 08, 2025

Pacira BioSciences (NASDAQ:PCRX) Raised to Buy at Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 21,781 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Connect - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira (PCRX) BioSciences Grants Inducement Awards to New Employ - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira Expands Team: 19 New Hires Receive $1.8M in Stock Awards and Options - Stock Titan

Jun 05, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Purchases 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Q3 EPS Estimate for Pacira BioSciences Raised by Analyst - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 01, 2025
pulisher
May 30, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 30, 2025
pulisher
May 30, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by ProShare Advisors LLC - Defense World

May 30, 2025
pulisher
May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Pacira BioSciences’s First Quarter 2025 Misses Estimates - Orthopedics This Week

May 29, 2025
pulisher
May 28, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Nuveen Asset Management LLC - Defense World

May 28, 2025
pulisher
May 26, 2025

Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire

May 26, 2025
pulisher
May 25, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Reach Out - ACCESS Newswire

May 25, 2025
pulisher
May 24, 2025

Trading (PCRX) With Integrated Risk Controls - news.stocktradersdaily.com

May 24, 2025
pulisher
May 24, 2025

Ameriprise Financial Inc. Acquires 194,597 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 24, 2025
pulisher
May 24, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of “Hold” from Brokerages - Defense World

May 24, 2025
pulisher
May 22, 2025

Pacira BioSciences (NASDAQ:PCRX) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 57% - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

Pacira at RBC Conference: Strategic Growth and Gene Therapy Focus - Investing.com

May 21, 2025
pulisher
May 18, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

May 18, 2025
pulisher
May 18, 2025

2025-05-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Shareholders to Inquire about Securities Investigation | Press Release - Stockhouse

May 18, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Sells 458 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 18, 2025
pulisher
May 17, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Comerica Bank - Defense World

May 17, 2025
pulisher
May 17, 2025

Northern Trust Corp Buys 145,205 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 17, 2025
pulisher
May 15, 2025

PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira (PCRX) Reports Promising Data on PCRX-201 Gene Therapy fo - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira (PCRX) Reports Promising Data on PCRX-201 Gene Therapy for Knee Osteoarthritis | PCRX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Pacira BioSciences Presents New Data on the Effects of - GlobeNewswire

May 15, 2025

Pacira Biosciences Inc Azioni (PCRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Pacira Biosciences Inc Azioni (PCRX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
WILLIAMS KRISTEN
Chief Administrative Officer
Jun 04 '25
Sale
26.24
14,376
377,226
161,574
$14.72
price up icon 2.01%
$9.34
price up icon 1.74%
$129.40
price up icon 1.09%
$295.22
price up icon 1.48%
drug_manufacturers_specialty_generic RDY
$14.88
price down icon 0.40%
$17.05
price up icon 2.46%
Capitalizzazione:     |  Volume (24 ore):